This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Insulet’s US trade secret award cut by $393 million; injunction granted

By Nick Robertson ( April 28, 2025, 14:04 GMT | Insight) -- The US District of Massachusetts entered a permanent injunction against EOFlow Co. in a trade secret lawsuit by rival Insulet Corp., with temporary carve outs to allow current EU and South Korean patents to continue using EOFlow’s “EOPatch 2” insulin patch device while they seek alternative care. The judge also reduced the damage award from $452 million to $59 million, citing in part statutory limits under the Defend Trade Secrets Act on exemplary damages, and denied EOFlow’s motion for a new trial.A US District of Massachusetts judge slashed the trade secret misappropriation award against EOFlow Co. related to rival Insulet Corp.’s insulin patch pumps from $452 million to $59 million, based in part on statutory caps on exemplary damages, while also denying the company a new trial....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections